| [1] Rahman A, Khan KM, Al-Khaledi G, et al. Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats[J]. Neurotoxicology, 2012, 33(3):370-383.[2] Wirbisky SE, Weber GJ, Lee JW, et al. Novel dose-dependent alterations in excitatory GABA during embryonic development associated with lead (Pb) neurotoxicity[J]. Toxicol Lett, 2014, 229(1):1-8.[3] Zheng W, Aschner M, Ghersi-Egea JF. Brain barrier systems:a new frontier in metal neurotoxicological research[J]. Toxicol Appl Pharmcol, 2003, 192 (1):1-11.[4] Zheng W, Monnot AD. Regulation of brain iron and copper homeostasis by brain barrier systems:Implication in neurodegenerative diseases[J]. Pharmacol Ther, 2012, 133(2):177-188.[5] Zheng W. Toxicology of choroid plexus:Special reference to metal-induced neurotoxicities[J]. Microsc Res and Tech, 2001, 52(1):89-103.[6] Friedheim E, Corvi C, Graziano J, et al. Choroid plexus as protective sink for heavy metals? [J]. Lancet, 1983, 1(8331):981-982.[7] Zheng W, Perry DF, Nelson DL, et al. Choroid plexus protects cerebrospinal fluid against toxic metals[J]. Faseb J, 1991, 5(8):2188-2193.[8] Gu HY, Wei X, Monnot AD, et al. Lead exposure increases levels of beta-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice [J]. Neurosci Lett, 2011, 490(1):16-20.[9] Shi LZ, Zheng W. Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro[J]. Hum Exp Toxicol, 2007, 26(3):159-167.[10] 王红梅, 刘 羽, 刘君丽, 等. 乙酸铅对脑脉络丛Z310细胞毒性作用[J]. 中国公共卫生, 2012, 28(9):1202-1204.[11] 王红梅, 刘 羽, 董一文, 等. 乙酸铅对Z310细胞周期和PHB1蛋白表达的影响研究[J]. 毒理学杂志, 2013, 27(4):265-268.[12] 刘 羽, 董一文, 胡 红, 等. VDAC1基因低表达型Z310细胞系的建立与乙酸铅对其增殖的影响[J]. 毒理学杂志, 2014, 28(1):19-25.[13] Randall C, Mosconi L, de Leon M, et al. Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly[J]. Front Biosci, 2013, 18:1150-1173.[14] Behl M, Zhang YS, Shi YZ, et al. Lead-induced accumulation of β-amyloid in the choroid plexus:role of low density lipoprotein receptor protein-1 and protein kinase C[J]. Neurotoxicology, 2010, 31(5): 524-532.[15] Behl M, Zhang Y, Zheng W. Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure[J]. Cerebrospinal Fluid Res, 2009, 6(1):1-11.[16] Schreiber G, Richardson SJ, Prapunpoj P. Structure and expression of the transthyretin gene in the choroid plexus:a model for the study of the mechanism of evolution[J]. Microsc Res Tech, 2001, 52(1):21-30.[17] Bernal J. Thyroid hormones and brain development[J]. Vitam Horm, 2005, 71(1):95-122.[18] Zheng W, Shen H, Blaner SB, et al. Chronic lead exposure alters transthyretin concentration in rat cerebrospinal fluid:The role of the choroid plexus[J]. Toxicol Appl Pharmacol, 1996, 139(2):445-450.[19] Zheng W, Blaner WS, Zhao QQ. Inhibition by lead of production and secretion of transthyretin in the choroid plexus:its relation to thyroxine transport at blood-CSF barrier[J]. Toxicol Appl Pharmacol, 1999, 155(1):24-31.[20] Gainer M. Diacylglycerol inhibits gap junction communication in cultured epithelial cells:evidence for a role of protein kinase C[J]. Biochim Biophys Res Commun, 1985, 126(3):1109-1113.[21] Zhao Q, Slavkovich V, Zheng W. Lead exposure promotes translocation of protein kinase C activity in rat choroid plexus in vitro, but not in vivo[J]. Toxicol Appl Pharmacol, 1998, 149(1):99-106.[22] Struzynska L, Walski M, Gadamski R, et al. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity[J]. Mol Chem Neuropathol, 1997, 31(3):207-224.[23] Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration [J]. J Alzheimers Dis, 2006, 10(2/3):223-253.[24] Wang Q, Luo WJ, Zhang WB, et al. a Involvement of DMT1+ IRE in the transport of lead in an in vitro BBB model[J]. Toxicol in Vitro, 2011, 25(4):991-998.[25] Balbuena P, Li W, Geraldine MBJ, et al. Comparison of two blood-brain barrier in vitro systems:Cytotoxicity and transfer assessments of malathion/oxon and lead acetate[J]. Toxicol Sci, 2010, 114(2):260-271.[26] Press MF. Lead encephalopathy in neonatal Long-Evans rats: morphologic studies[J]. J Neuropathol Exp Neurol, 1977, 36(1):169-193.[27] Song H, Zheng G, Shen XF, et al. Reduction of brain barrier tight junctional proteins by lead exposure:role of activation of nonreceptor tyrosine kinase Src via chaperon GRP78[J]. Toxicol Sci, 2014, 138(2):393-402.[28] Zhu Y, Fan Q, Mao H, et al. GRP78 from grass carp (Ctenopharyn-godon idella) provides cytoplasm protection against thermal and Pb2+ stress[J]. Fish Shellfish Immunol, 2013, 34(2):617-22.[29] Tiffany-Castiglioni E, Qian Y. ER chaperone-metal interactions: Links to protein folding disorders[J]. Neurotoxicology, 2012, 33(3): 545-557.[30] Silbergeld EK, Wolinsky JS, Goldstein GW. Electron probe micro-analysis of isolated brain capillaries poisoned with lead[J]. Brain Res, 1980, 189(2):369-376.[31] Kim KA, Chakraborti T, Goldstein GW, et al. Immediate early gene expression in PC12 cells exposed to lead:requirement for protein kinase C[J]. J Neurochem, 2000, 74(3):1140-1146.[32] Hossain MA, Bouton CM, Pevsner J, et al. Induction of vascular endothelial growth factor in human astrocytes by lead involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway[J]. J Biol Chem, 2000, 275(36):27874-27882.[33] Rai A, Maurya SK, Khare P, et al. Characterization of developmental neurotoxicity of As, Cd, and Pb mixture:synergistic action of metal mixture in glial and neuronal functions[J]. Toxicol Sci, 2010, 118(2): 586-601.[34] Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity[J]. Biochem Pharmacol, 1991, 41(4):479-484.[35] Wang Q, Luo W, Zheng W, et al. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development[J]. Toxicol Appl Pharmacol, 2007, 219(1):33-41. |
